Delivery Order SPE2DB22D9316-SPE2DB25FYP02
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,673.67 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a pharmaceutical supply requirement to support Department of Defense healthcare operations. The award was made without a set-aside designation, and the products will be delivered to Park Ridge, Illinois, where the...
- The Defense Logistics Agency awarded a $3,416.18 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 250 microgram vials of Nplate. The award, issued on November 11, 2025, carries an ultimate completion date of December 3, 2025, and was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is...
- The Defense Logistics Agency awarded a $6,697.06 delivery order to DMS Pharmaceutical Group Inc. on July 28, 2025, for the supply of Nplate 500 microgram vials, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a pharmaceutical supply fulfillment for federal healthcare needs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves...
- The Defense Logistics Agency awarded a $10,042.02 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of NPLATE 250 micrograms vials. The delivery order, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nplate 250 microgram vials. This $1,673.67 firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes no set-aside designation and is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,394.12 to DMS Pharmaceutical Group Inc. for 500 microgram vials of Nplate on September 24, 2025. This firm fixed-price delivery order, which must be completed by October 16, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. Nplate is a prescription...
- The Defense Logistics Agency awarded a $25,111 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nplate 500 microgram vials. This firm fixed-price delivery order was issued on October 29, 2025, with an ultimate completion date of November 20, 2025, and requires performance at the contractor's Park Ridge facility. The award carries no set-aside designation, indicating the contractor...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,697.06 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Nplate 500 microgram vials. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifteen thousand five hundred sixty-seven dollars ($15,567) by the Defense Logistics Agency. This order is being issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will provide two hundred fifty (250) microgram...
- The Defense Logistics Agency awarded a delivery order valued at $6,697.06 to DMS Pharmaceutical Group Inc. for the supply of Nplate 500 microgram vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform work at its Park Ridge facility with an ultimate completion date of August 14, 2025. This delivery order utilizes a firm fixed-price contract type with no set-aside designation, allowing the company to compete on a...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB25FYP02Delivery Order
The Defense Logistics Agency awarded a $10,042.02 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 250 microgram vials of Nplate. The delivery order, issued May 12, 2025, with completion targeted for June 3, 2025, carries no set-aside designation. DMS Pharmaceutical Group leverages its position as a woman-owned small business to compete in federal procurement while fulfilling this pharmaceutical supply requirement for the Department of Defense healthcare system. This delivery order executes under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 through November 2026. The parent contract enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide, spanning branded and generic prescription drugs, biologics, injections, and specialty medications. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group maintains consistent delivery performance across diverse medical product categories to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 5/12/25 |